Evidence map›Paper›PMID 39402617›Full record

ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2024

Oral immunotherapy improves the quality of life of adults with food allergy.

Na'ama Epstein-Rigbi, Michael B Levy, Liat Nachshon, Yael Koren, Michael R Goldberg, Arnon Elizur

Abstract read
In one paragraph

Article in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Quality of life and psychological wellbeing of adults with anaphylaxis: a mixed method systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Na'ama Epstein-RigbiThe Institute of Allergy, Immunology and Pediatric Pulmonology, Shamir Medical Center (Former Assaf Harofeh), 71300, Be'er Ya'akov, Israel. naamaepstein@gmail.com.
Michael B LevyThe Institute of Allergy, Immunology and Pediatric Pulmonology, Shamir Medical Center (Former Assaf Harofeh), 71300, Be'er Ya'akov, Israel.
Liat NachshonThe Institute of Allergy, Immunology and Pediatric Pulmonology, Shamir Medical Center (Former Assaf Harofeh), 71300, Be'er Ya'akov, Israel.
Yael KorenThe Institute of Allergy, Immunology and Pediatric Pulmonology, Shamir Medical Center (Former Assaf Harofeh), 71300, Be'er Ya'akov, Israel.
Michael R GoldbergThe Institute of Allergy, Immunology and Pediatric Pulmonology, Shamir Medical Center (Former Assaf Harofeh), 71300, Be'er Ya'akov, Israel.
Arnon ElizurThe Institute of Allergy, Immunology and Pediatric Pulmonology, Shamir Medical Center (Former Assaf Harofeh), 71300, Be'er Ya'akov, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral immunotherapy (OIT) has become the standard of care for children with food allergy (FA) and has substantially improved their quality of life. The effect of OIT on the quality of life in adults, however, has been studied to a much lesser degree.

methodsPatients with food allergy aged ≥ 18 years who underwent OIT at Shamir Medical Center completed the Food Allergy Quality of Life Questionnaire-Adult Form (FAQLQ-AF) before and at the end of treatment. Adults with FA not undergoing OIT who completed the FAQLQ-AF at 2 time points, served as controls.

resultsA total of 44 adults, median age 23.4 years, who underwent OIT for milk (n = 19), egg (n = 2), peanut (n = 9), sesame (n = 6), and tree nuts (n = 8), and 11 controls were studied. The median OIT starting dose was 23.8 mg protein. 33 patients (75%) reached full desensitization within a median of 10.3 months. The FAQLQ-AF baseline scores were comparable between the study and control groups for all items except for Food Allergy related Health (FAH) item in which the study group had a significantly better score (p = 0.02). At the second time point, the study group had significantly better scores in all items (Allergen Avoidance and Dietary Restrictions (AADR), p = 0.02; and Emotional Impact (EI), Risk of Allergen Exposure (RAE), FAH and the Total Score, p < 0.01). The change in scores for the study group was significantly better, statistically and clinically, in AADR, p = 0.04; EI, p < 0.01; RAE, p = 0.01, and in the total score, p = 0.01.

conclusionsOIT significantly improves quality of life of adults with FA. This finding adds important support for providing OIT in this population.

Indexed as

AdultsFood allergyOral immunotherapyQuality of life

Identifiers

PMID39402617
PMCPMC11472437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.